Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori Group.
Queirolo P, Ponte M, Gipponi M, Cafiero F, Peressini A, Semino C, Pietra G, Lionetto R, Vecchio S, Ribizzi I, Melioli G, Sertoli MR. Queirolo P, et al. Among authors: ponte m. Ann Surg Oncol. 1999 Apr-May;6(3):272-8. doi: 10.1007/s10434-999-0272-4. Ann Surg Oncol. 1999. PMID: 10340886 Clinical Trial.
Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2.
Melioli G, Guastella M, Semino C, Meta M, Pietra G, Ponte M, Queirolo P, Sertoli MR, Martini L, Reali UM. Melioli G, et al. Among authors: ponte m. Melanoma Res. 1994 Apr;4(2):127-33. doi: 10.1097/00008390-199404000-00007. Melanoma Res. 1994. PMID: 8069098
A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinoma.
Ratto GB, Zino P, Mirabelli S, Minuti P, Aquilina R, Fantino G, Spessa E, Ponte M, Bruzzi P, Melioli G. Ratto GB, et al. Among authors: ponte m. Cancer. 1996 Jul 15;78(2):244-51. doi: 10.1002/(SICI)1097-0142(19960715)78:2<244::AID-CNCR9>3.0.CO;2-L. Cancer. 1996. PMID: 8673999 Clinical Trial.
Treatment of stage IIIB non-small-cell lung cancer with surgery followed by infusion of tumor infiltrating lymphocytes and recombinant interleukin-2: a pilot study.
Melioli G, Ratto GB, Ponte M, Guastella M, Semino C, Fantino G, Tassara E, Pasquetti W, Mereu C, Merlo F, Reggiardo G, Morasso G, Santi L, Moretta L. Melioli G, et al. Among authors: ponte m. J Immunother Emphasis Tumor Immunol. 1996 May;19(3):224-30. doi: 10.1097/00002371-199605000-00007. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8811497
Stimulatory receptors in NK and T cells.
Moretta A, Sivori S, Ponte M, Mingari MC, Moretta L. Moretta A, et al. Among authors: ponte m. Curr Top Microbiol Immunol. 1998;230:15-23. doi: 10.1007/978-3-642-46859-9_2. Curr Top Microbiol Immunol. 1998. PMID: 9586347 Review. No abstract available.
178 results